Clinical trial Recruiting at 1 site Interventional Ages 10 and up

Support program for Hong Kong–Shenzhen cross-boundary families

Official title: Jockey Club Support Project to Enhance Emotion Regulation Skills and Resilience of Cross-Boundary Families: A Randomized Controlled Trial

Run by City University of Hong Kong · NCT07136064 · Data updated 2026-11-12

This program tests whether group emotion-regulation and electronics-use sessions for Shenzhen-based parent–child pairs can help them become more resilient, reduce family conflict, and improve well-being.

Quick facts

Study typeInterventional
Ages10 Years and up
SexAll
Enrollment450 (estimated)
SponsorCity University of Hong Kong
Academic / other
Locations1 site (Shenzhen, Guangdong)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedApril 2028
Study endsAugust 2028
Registry record updatedFebruary 12, 2026
Trial IDNCT07136064 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parent–child pairs where the child is in grades 5–12, both live in Shenzhen, and at least one family member is a Hong Kong resident and able to attend the scheduled sessions.

Probably not a fit

Those with current severe physical or mental illnesses, or families who do not live in Shenzhen or lack Hong Kong residency ties, are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial recruiting Hong Kong–linked families who live in Shenzhen, with parent–child pairs randomized in a 2:1 ratio to the intervention or control arm. Parents attend four group activity sessions and children attend two condensed sessions that teach emotion-regulation skills and moderation in consumer electronics use. Outcomes include changes in resilience, emotion regulation, psychological well-being, family harmony, and social connectedness. The project is run in collaboration with the International Social Service Hong Kong Branch (Shenzhen) and funded by the Hong Kong Jockey Club Charities Trust and City University of Hong Kong.

Why it matters

Potential benefit: If successful, the program could strengthen parents' and children's emotion‑regulation skills, lower family conflict, and boost resilience and psychological well‑being.

How similar studies have gone: Similar family-based emotion‑regulation interventions have shown modest improvements in youth emotion regulation and family functioning, but the cross‑boundary Hong Kong–Shenzhen context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for Parents:

1. have at least one child between the fifth and twelfth grade;
2. can participate in the intervention with their child;
3. are Hong Kong residents or have a family member who is a Hong Kong resident;
4. live in Shenzhen.

Inclusion Criteria for Children:

1. are between the fifth and twelfth grade;
2. are Hong Kong residents or have a family member who is a Hong Kong resident;
3. live in Shenzhen.

Exclusion Criteria:

(a) those who have current diagnoses of severe physical or mental illnesses;

Where it's running

  • International Social Service Hong Kong Branch
    Shenzhen, Guangdong, China
    Recruiting

Study contacts

  • Principal investigator: Nancy X Yu, Doctoral — City University of Hong Kong
  • Study coordinator: Nancy X Yu, Doctoral
  • Email: nancy.yu@cityu.edu.hk
  • Phone: 85234429436

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.